SMi-11958

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSMi-11958
Drug Alias NameSrc inhibitors (SMi)Src inhibitors (MD Anderson Cancer Center)Src inhibitors (Systems Medicine)SMi-8829SMi-813
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase SRC inhibitorsAnticancer protein kinase inhibitors
TargetsTyrosine-protein kinase SRC
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSystems Medicine LlcCti Biopharma CorpThe University Of Texas MD Anderson Cancer Center
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A